Semiquantitative assessment of surgical lung biopsy: predictive value and impact on survival of patients with diffuse pulmonary infiltrate

Clinics

Volumn 62, Issue 1, 2007, Pages 23-30

  Canzian, Mauro ^a   Soeiro, Alexandre De Matos ^a   Taga, Marcel Frederico De Lima ^b   Farhat, Cecília ^a   Barbas, Carmen Silvia Valente ^a   Capelozzi, Vera Luiza ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diffuse alveolar damage; Diffuse pulmonary infiltrate; Histopathological score; Prognosis; Surgical lung biopsy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; BRAZIL; BRONCHIOLITIS; EPIDEMIOLOGY; FEMALE; HUMAN; LENGTH OF STAY; LUNG; LUNG ALVEOLUS; LUNG DISEASE; LUNG FIBROSIS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SEX DIFFERENCE; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRAZIL; BRONCHIOLITIS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LENGTH OF STAY; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY ALVEOLI; PULMONARY FIBROSIS; SEX FACTORS; VASCULITIS;

EID: 33847656736     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322007000100005     Document Type: Article

References (25)

1. Lipford EH 3rd, Eggleston JC, Lillemoe KD, Sears DL, Moore GW, Baker RR. Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung. Am J Surg Pathol. 1984;8:357-65.
2. Elson CE, Roggli VL, Vollmer RT, Greenberg SD, Fraire AE, Spjut HJ, et al. Prognostic indicators for survival in stage I carcinoma of the lung: a histologic study of 47 surgically resected cases. Mod Pathol. 1988;1:288-91.
3. Lee TK, Horner RD, Silverman JF, Chen YH, Jenny C, Scarantino CW. Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells. Cancer. 1989;63:309-16.
4. Kodama T, Nishiyama H, Nishiwaki Y. Histology and prognosis in lung cancer treatment. Nihon Kyobu Shikkan Gakkai Zasshi. 1990; 28:216-24.
5. Shahab I, Fraire AE, Greenberg SD, Johnson EH, Langston C, Roggli VL. Morphometric quantitation of tumor necrosis in stage 1 non-small cell carcinoma of lung: prognostic implications. Mod Pathol. 1992;5:521-4.
6. Cherniack RM, Colby TV, Flint A, Thurlbeck WM, Waldron J, Ackerson L, et al. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1991;144:892-900.
7. Hyde DM, King TE Jr, McDermott T, Waldron JA Jr, Colby TV, Thurlbeck WM, et al. Idiopathic pulmonary fibrosis. Quantitative assessment of lung pathology. Comparison of a semiquantitative and a morphometric histopathologic scoring system. Am Rev Respir Dis. 1992;146:1042-7.
8. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med. 2001;164:1171-81.
9. Gutierrez EB, Zanetta DM, Saldiva PH, Capelozzi VL. Autopsy-proven determinants of death in HIV-infected patients treated for pulmonary tuberculosis in Sao Paulo, Brazil. Path Res Pract. 2002;198:339-46.
10. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1986;133:97-103.
11. Gay SE, Kazerooni EA, Toews GB Lynch JP 3rd, Gross BH, Cascade PN, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1063-72.
12. King TE Jr, Schwarz MI, Brown K Tooze JA, Colby TV, Waldron JA Jr, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001;164:1025-32.
13. Bove P, Ranger W, Pursel S, Glover J, Bove K, Bendick P. Evaluation of outcome following surgical lung biopsy. Am Surg. 1994;60:564-70.
14. Patel SR, Karmpaliotis D, Ayas NT, Mark EJ, Wain J, Thompson BT, et al. The role of surgical-lung biopsy in ARDS. Chest. 2004,125:197-202.
15. Potter D, Pass HI, Brower S, Macher A, Browne M, Thaler M et al. Prospective randomized study of surgical lung biopsy versus empirical antibiotic therapy for acute pneumonitis in nonneutropenic cancer patients. Ann Thorac Surg. 1985;40:422-8.
16. Blewett CJ, Bennett WF, Miller JD, Urschel JD. Open lung biopsy as an outpatient procedure. Ann Thorac Surg. 2001;71:1113-5.
17. Rossiter SJ, Miller C, Churg AM, Carrington CB, Mark JB. Open lung biopsy in the immunosuppressed patient. Is it really beneficial? J Thorac Cardiovasc Surg. 1979;77:338-45.
18. Walker WA, Cole FH Jr, Khandekar A, Mahfood SS, Watson DC. Does open lung biopsy affect treatment in patients with diffuse pulmonary infiltrates? J Thorac Cardiovasc Surg. 1989;97:534-40.
19. Canver CC, Mentzer RM Jr. The role of open lung biopsy in early and late survival of ventilator-dependent patients with diffuse idiopathic lung disease. J Cardiovasc Surg (Torino). 1994;35:151-5.
20. Kramer MR, Berkman N, Mintz B, Godfrey S, Saute M, Amir G, et al. The role of open lung biopsy in the management and outcome of patients with diffuse lung disease. Ann Thorac Surg. 1998;65:198-202.
21. Flabouris A, Myburgh J. The utility of open lung biopsy in patients requiring mechanical ventilation. Chest. 1999;115:811-7.
22. Papazian L, Thomas P, Bregeon F, Garbe L, Zandotti C, Saux P, et al. Open-lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology. 1998;88:935-44.
23. Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg. 1980;30:411-26.
24. Venn GE, Kay PH, Midwood CJ, Goldstraw P. Open lung biopsy in patients with diffuse pulmonary shadowing. Thorax. 1985;40:931-5.
25. Shah SS, Tsang V, Goldstraw P. Open lung biopsy: a safe, reliable and accurate method for diagnosis in diffuse lung disease. Respiration. 1992;59:243-6.